Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Ponferrada, Spain Clinical Trials

A listing of Ponferrada, Spain clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

This is a national, multicentre, observational, retrospective, open-label, non-randomized, non-interventional study to evaluate the degree of compliance at PETHEMA centres in Spain with the clinical practice guidelines proposed by the Spanish Myeloma Group for the treatment of relapsed and refractory MM with POMCIDEX. In this study, all patients will be ...

Phase N/A

0.0 miles

Learn More »

Spanish Bacteriemia Cohort 2016: Epidemiology Clinical Management and Prognosis Factors

Bacteremia The Hypothesis of the study are the followings: To demonstrate relevant epidemiologic and clinical changes with potentially impact in the management and prognosis of the patients with bacteremia. Since the diagnosis and management is heterogeneous between centers, we could identify a scenario to improve. To identify quality indicators in ...

Phase N/A

2.27 miles

Learn More »

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

2.82 miles

Learn More »

Prevalence of Severe Asthma in Spanish Hospitals

Asthma is a chronic disease. Prevalence of asthma in 2014 among Spanish population was 5%, of which 10% were diagnosed with severe asthma. According to Spanish National Guideline for the Management of Asthma (GEMA) 4.1 criteria, asthma can be classified according to its severity (intermittent, mild persistent, moderate persistent or ...

Phase N/A

2.82 miles

Learn More »